S. 2354 · 109th Congress
Medicare Prescription Drug Gap Reduction Act of 2006
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
NelsonSponsor18 cosponsors · 17 D, 1 R
D
Boxer
SC
R
Collins
BD
D
Dorgan
RF
D
Feingold
JK
D
Kerry
HK
D
Kohl
BM
D
Mikulski
JR
D
Rockefeller
TJ
D
Johnson
CS
D
Schumer
HC
D
Clinton
TH
D
Harkin
FL
D
Lautenberg
KS
D
Salazar
JL
D
Lieberman
MC
D
Cantwell
PS
D
Sarbanes
MP
D
Pryor8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Medicare Prescription Drug Gap Reduction Act of 2006 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices.
What it does: CRS summary · Introduced in Senate · Mar 2, 2006
Medicare Prescription Drug Gap Reduction Act of 2006 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices.
Grants the Secretary of Health and Human Services authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs.
States that the Secretary shall be required to: (1) negotiate contracts with manufacturers of covered part D drugs for each fallback prescription drug plan; and (2) participate in negotiation of contracts of any covered part D drug upon request of an approved prescription drug plan or Medicare Advantage Prescription Drug Plan.
Prohibits the Secretary from requiring a particular formulary or instituting a price structure for the reimbursement of covered part D drugs in order to carry out, and promote competition, under part D.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare Prescription Drug Gap Reduction Act of 2006
Latest action (Mar 2, 2006): Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1645-1646)
Policy area: Health · Origin: Senate · Introduced: Mar 2, 2006
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.